Bio-Path Holdings, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Gillian C Ivers-read. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Gillian C Ivers-read has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CLVS / Clovis Oncology Inc See Remarks 293,612
US:BPTH / Bio-Path Holdings, Inc. Director 25,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Gillian C Ivers-read. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BPTH / Bio-Path Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BPTH / Bio-Path Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Insider Sales BPTH / Bio-Path Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BPTH / Bio-Path Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Gillian C Ivers-read as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,006 293,612 -0.68 0.98 -1,972 288,591
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,675 290,993 -0.57 0.98 -1,646 286,017
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 295,618 1.59
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 292,668 1.30
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,234 288,919 -0.77 1.20 -2,681 346,703
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,063 291,153 1.77
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,100 286,090 -0.73 1.46 -3,068 417,977
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,702 283,565 -0.60 1.46 -2,487 414,288
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 288,190 1.63
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 285,267 1.33
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,327 281,518 -0.82 0.64 -1,495 180,847
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,062 283,845 1.82
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,062 278,783 -0.73 1.97 -4,062 549,147
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,671 276,220 -0.60 1.97 -3,292 544,098
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 32,375 -12.50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 11,248 -25.00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 280,845 1.67
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 277,891 1.37
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10,416 274,142 -3.66 1.87 -19,436 511,549
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -354 264,308 -0.13 1.87 -661 493,199
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 0 -100.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20,250 60,750 50.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20,250 284,558 7.66
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 264,662 0.26
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,453 263,974 -0.92 1.94 -4,758 512,057
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,989 261,802 -0.75 1.94 -3,858 507,791
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 37,000 -11.11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,750 14,997 -20.00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 266,427 1.77
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,750 263,791 1.44
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 260,041 -0.12 3.00 -912 780,123
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 688 -49.96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 260,345 0.26
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,041 259,658 -0.78 4.55 -9,287 1,181,444
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,655 257,074 -0.64 4.55 -7,530 1,169,687
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 41,625 -10.00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 18,747 -16.67
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 261,699 1.80
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 258,729 1.47
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 254,980 -0.12 4.89 -1,487 1,246,852
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 1,375 -33.35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 255,284 0.27
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,034 254,596 -0.79 4.82 -9,804 1,227,153
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,649 252,005 -0.65 4.82 -7,948 1,214,664
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 46,150 -9.11
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 22,496 -14.28
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 256,630 1.84
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 253,654 1.50
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -283 249,905 -0.11 5.63 -1,593 1,406,965
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 687 2,063 49.93
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 250,188 0.28
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,183 249,501 -0.87 5.54 -12,094 1,382,236
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,769 247,059 -0.71 5.54 -9,800 1,368,707
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 50,875 -8.33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 26,245 -12.50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 251,684 1.87
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 248,828 1.53
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 245,079 -0.12 6.29 -1,912 1,541,547
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -276 244,695 -0.11 6.29 -1,736 1,539,132
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 2,750 33.37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 625 0 -100.00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 245,383 0.28
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 244,971 0.26
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9,031 244,346 -3.56 7.97 -71,977 1,947,438
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,959 234,877 -0.83 7.97 -15,613 1,871,970
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18,500 55,500 -25.00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,750 29,994 -11.11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18,500 253,377 7.88
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,750 236,836 1.61
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 0 -100.00
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 233,086 -0.35 5.68 -4,709 1,323,928
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 233,915 0.81
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -68,965 0 -100.00
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -52,447 232,040 -18.44 4.81 -252,270 1,116,112
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 68,965 284,487 32.00 3.28 226,205 933,117
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 3,438 -16.65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 625 -50.00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 215,522 -0.14 4.89 -1,487 1,053,903
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 215,826 0.32
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -277 215,139 -0.13 4.89 -1,355 1,052,030
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 215,416 0.29
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 33,744 -10.00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,689 214,791 -0.78 4.93 -8,327 1,058,920
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 216,480 1.76
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 1,875 -50.00
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 212,731 -0.39 6.85 -5,679 1,457,207
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9 213,560 0.00 6.86 -62 1,465,022
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 213,569 0.89
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 4,125 -14.29
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1,250 -33.33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -290 211,694 -0.14 5.30 -1,537 1,121,978
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 211,984 0.33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -263 211,296 -0.12 5.30 -1,394 1,119,869
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 211,559 0.30
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 37,493 -9.09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,670 210,934 -0.79 5.92 -9,886 1,248,729
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 212,604 1.80
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 3,750 -33.33
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 208,855 -0.40 6.74 -5,587 1,407,683
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 209,684 0.90
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 4,813 -12.49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1,875 -25.00
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -313 207,809 -0.15 7.03 -2,200 1,460,897
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 208,122 0.33
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -285 207,435 -0.14 7.03 -2,004 1,458,268
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 207,720 0.30
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 41,242 -8.33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,475 207,095 -0.71 8.10 -11,948 1,677,470
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 208,570 1.83
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 5,625 -25.00
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 204,821 -0.40 4.60 -3,813 942,177
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 205,650 0.92
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 5,500 -11.12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 2,500 -20.00
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -317 203,775 -0.16 7.20 -2,282 1,467,180
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 204,092 0.34
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -288 203,404 -0.14 7.20 -2,074 1,464,509
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 203,692 0.31
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -14,997 44,991 -25.00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7,204 203,067 -3.43 8.41 -60,586 1,707,793
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 14,997 210,271 7.68
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74,000 74,000
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 7,500 -20.00
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -830 195,274 -0.42 11.30 -9,379 2,206,596
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 196,104 0.97
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 6,188 -9.99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3,125 -16.67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -310 194,229 -0.16 14.59 -4,523 2,833,801
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 194,539 0.35
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -282 193,852 -0.15 14.60 -4,117 2,830,239
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 194,134 0.32
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 9,375 -16.67
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -837 193,509 -0.43 4.80 -4,018 928,843
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 194,346 0.97
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 6,875 -9.10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3,750 -14.29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -330 192,471 -0.17 5.21 -1,719 1,002,774
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 192,801 0.36
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -300 192,113 -0.16 5.21 -1,563 1,000,909
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 192,413 0.33
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 11,250 -14.29
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 191,788 -0.43 14.70 -12,186 2,819,284
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 192,617 0.98
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 7,563 -8.33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 4,375 -12.50
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -302 190,742 -0.16 15.07 -4,551 2,874,482
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 191,044 0.36
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -275 190,357 -0.14 15.07 -4,144 2,868,680
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 190,632 0.33
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 13,125 -12.50
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -830 190,007 -0.43 26.13 -21,688 4,964,883
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 190,837 0.99
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,750 8,250 -25.00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5,000 -11.11
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,295 188,962 -0.68 29.29 -37,931 5,534,697
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,750 190,257 1.47
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -316 187,507 -0.17 29.29 -9,256 5,492,080
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 187,823 0.33
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59,988 59,988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19,996 19,996
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 15,000 -11.11
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 187,198 -0.44 17.72 -14,690 3,317,149
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 188,027 1.01
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5,625 -10.00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -250 186,152 -0.13 21.23 -5,308 3,952,007
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 186,402 0.34
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 16,875 -10.00
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 185,777 -0.44 32.21 -26,702 5,983,877
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 186,606 1.01
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6,250 -9.09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -282 184,731 -0.15 35.75 -10,082 6,604,133
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 185,013 0.34
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 18,750 -9.09
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 184,388 -0.45 45.75 -37,927 8,435,751
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 185,217 1.02
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6,875 -8.33
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -278 183,342 -0.15 47.70 -13,261 8,745,413
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 183,620 0.34
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 20,625 -8.33
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 182,995 -0.45 56.75 -47,046 10,384,966
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 183,824 1.03
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,500 7,500 -25.00
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1,122 181,949 -0.61 58.43 -65,558 10,631,280
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,500 183,071 1.38
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 11,000 11,000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 11,000 11,000
2018-02-16 2018-02-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 180,571 -1.63 54.09 -162,270 9,767,085
2018-01-17 2018-01-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 183,571 -1.61 59.16 -177,480 10,860,060
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -7,500 22,500 -25.00
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -3,512 186,571 -1.85 63.80 -224,066 11,903,230
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 7,500 190,083 4.11
2017-12-18 2017-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 182,583 -1.62 64.16 -192,480 11,714,525
2017-11-16 2017-11-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 185,583 -1.59 63.70 -191,100 11,821,637
2017-10-17 2017-10-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 188,583 -1.57 84.54 -253,620 15,942,807
2017-09-18 2017-09-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 191,583 -1.54 69.50 -208,500 13,315,018
2017-08-15 2017-08-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 194,583 -1.52 70.05 -210,150 13,630,539
2017-07-17 2017-07-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 197,583 -1.50 91.56 -274,680 18,090,699
2017-06-15 2017-06-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 200,583 -1.47 61.82 -185,460 12,400,041
2017-05-15 2017-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 203,583 -1.45 47.39 -142,170 9,647,798
2017-04-17 2017-04-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 206,583 -1.43 56.02 -168,060 11,572,780
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 10,000 10,000
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2017-03-15 2017-03-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 209,583 -1.41 66.99 -200,970 14,039,965
2016-12-19 2016-12-19 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 30,000 30,000
2016-09-19 2016-09-16 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
J - Other -8,750 26,250 -25.00
2015-10-16 2015-10-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 212,583 -1.39 91.91 -275,730 19,538,504
2015-09-22 2015-09-18 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 215,583 -1.37 112.56 -337,680 24,266,022
2015-03-04 2015-03-02 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 35,000 35,000
2014-04-28 2014-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2014-01-14 2014-01-10 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 70,000 70,000
2013-04-26 2013-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2013-03-04 2013-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 75,000 75,000
2013-02-21 2013-02-19 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2012-03-05 2012-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 50,000 50,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)